Stockscreener 앱 받기
2.76
3.37%
0.09
시간 외 거래:
2.76
Cosciens Biopharma Inc 주식(CSCI)의 최신 뉴스
COSCIENS Biopharma halts investment in macimorelin; CMO to depart - Seeking Alpha
COSCIENS Biopharma Focuses on Natural Product Growth - TipRanks
Cosciens Biopharma provides update, reiterates pipeline prioritization - TipRanks
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization - GlobeNewswire
COSCIENS Biopharma Discontinues Key Drug Trial, Pivots to Natural Products Pipeline - StockTitan
CSCI stock touches 52-week low at $2.61 amid market challenges - Investing.com Australia
CSCI stock touches 52-week low at $2.61 amid market challenges By Investing.com - Investing.com South Africa
COSCIENS Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
This Biopharma Stock Could Be 2025’s Biggest Comeback Story - Wealth Awesome
Aeterna Zentaris : to Present at Upcoming Biotech Showcase Conference in San Francisco - Marketscreener.com
CSCI stock touches 52-week low at $2.8 amid market challenges - Investing.com Canada
CSCI stock touches 52-week low at $2.8 amid market challenges By Investing.com - Investing.com South Africa
Canada Market's top losers: Draganfly Inc. with 13.78% drop, Digihost Technology Inc, 11.42% - Business Upturn
COSCIENS Biopharma Third Quarter 2024 Earnings: US$1.85 loss per share (vs US$3.41 loss in 3Q 2023) - Yahoo Finance
COSCIENS Biopharma: Q3 Earnings Snapshot - The Pioneer
COSCIENS Biopharma Advances Merger and Pipeline - TipRanks
Shimmick Announces New CEO - The Manila Times
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs - GlobeNewswire
COSCIENS Q3 Loss Widens to $5.8M, Discontinues Key Programs Amid Pipeline Shift | CSCI Stock News - StockTitan
CSCI stock touches 52-week low at $3.4 amid market fluctuations - Investing.com India
Hypoparathyroidism Market to Grow by USD 474.9 Million from 2024-2028, Driven by Thyroid Treatment Awareness Programs and AI-Powered Market InsightsTechnavio - PR Newswire
Cosciens Biopharma (TSX:CSCI) EPS without NRI : C$-4.32 (TTM As of Jun. 2024) - GuruFocus.com
AEterna Zentaris : March 10, 2015 Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2014 Financial and Operating Results on March 17, 2015 - Marketscreener.com
Yorvipath-finders? Septerna, others forge on in hypothyroidism - BioWorld Online
Cosciens Biopharma (FRA:ET8) Enterprise Value : €-13.18 Mil (As of Oct. 17, 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Cash From Discontinued Investi - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Profitability Rank : 5 (As of Jun. 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Shares Outstanding (EOP) : 3.06 Mil (As of Jun. 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Free Cash Flow : €-5.76 Mil (TTM As of Jun. 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Long-Term Debt & Capital Lease Obligation : €1.19 Mil (As of Jun. 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Inventory-to-Revenue : 1.40 (As of Jun. 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) 3-Year Revenue Growth Rate : -13.80% (As of Jun. 2024) - GuruFocus.com
Cosciens Biopharma (FRA:ET8) Cyclically Adjusted PS Ratio : 0.56 (As of Oct. 16, 2024) - GuruFocus.com
The Escalator: Syneos Health, The FDA, Pfizer and more - MM+M Online
COSCIENS Biopharma streamlines board with resignation By Investing.com - Investing.com Canada
COSCIENS Biopharma reshuffles board of directors By Investing.com - Investing.com South Africa
COSCIENS Biopharma streamlines board with resignation - Investing.com
COSCIENS Biopharma reshuffles board of directors - Investing.com India
Cosciens Biopharma director Carolyn Egbert resigns - TipRanks
COSCIENS Biopharma Restructures Board After Resignation - TipRanks
COSCIENS Biopharma Announces Change to Board of Directors - GlobeNewswire
AgEagle Aerial Systems Inc. Announces Closing of $6.5 Million Public Offering - The Manila Times
COSCIENS Biopharma names new board director By Investing.com - Investing.com South Africa
COSCIENS Biopharma names new board director - Investing.com
COSCIENS Biopharma Welcomes New Board Director - TipRanks
1.03%
자본화:
|
볼륨(24시간):